accessibility menu, dialog, popup

UserName
Viewing profile as user:

Lipid Controls

Materials used to calibrate and monitor the performance of lipid tests.
Detectable Analytes 
  • (2)
  • (2)
  • (2)
  • (2)
  • (2)
  • (2)
Form 
  • (2)
Boiling Point 
  • (1)
Molecular Weight (g/mol) 
  • (1)
Percent Purity 
  • (1)

Filtered Search Results

Products from some of our suppliers do not display in filtered search results. Please clear all filters to see these products.

Narrow Results

Narrow Results

category

brands

  • (2)
  • (1)
  • (2)
  • (6)
  • (1)
  • (26)
  • (224)
  • (1)
  • (5)
  • (3)
  • (83)
  • (2)
  • (2)
  • (2)
  • (1)
  • (17)
  • (34)
  • (1)
  • (3)
  • (1)
  • (1)
  • (1)
  • (15)
  • (2)
  • (144)
  • (1)
  • (3)
  • (2)
  • (3)
  • (1)
  • (1)
  • (1)
  • (1)
  • (1)
  • (12)
  • (1)
  • (1)
  • (2)
  • (2)
  • (1)
  • (1)

special interests

  • (570)

Detectable Analytes

  • (2)
  • (2)
  • (2)
  • (2)
  • (2)
  • (2)

Form

  • (2)

Boiling Point

  • (1)

Molecular Weight (g/mol)

  • (1)

Percent Purity

  • (1)

Quantity

  • (1)

Search Within Results
Keyword Search:
181 – 195 of 692 results
181

Medchemexpress LLC HY-145405 50mg , C12-200 CAS:1220890-25-4 Purity:>98%
SDP

HY-145405 50mg C12-200 CAS: 1220890-25-4 C12-200 is a benchmark ionizable cationic lipidoid along with helper lipids. C12-200 is commonly used for mRNA delivery. Purity:>98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.

ENCOMPASS_PREFERRED
182

Avanti Polar Lipids SPHINGOSINE-1-PHOSPHATE 1MG
SDP

Sphingosine-1-Phosphate 1mg

ENCOMPASS
183

Medchemexpress LLC HY-134781 5mg , CKK-E12 CAS:1432494-65-9 Purity:>98%
SDP

HY-134781 5mg CKK-E12 CAS: 1432494-65-9 CKK-E12 is a ionizable lipid in combination with other lipids make up the lipid nanoparticles which are used to deliver RNA-based therapeutics. cKK-E12 was highly selective toward liver parenchymal cell in vivo, Purity:>98% Medchemexpress has over 10000 novel life-science reagents, reference compounds, APIs and natural compounds for laboratory and scientific use. Other quantity can also be offered.

ENCOMPASS_PREFERRED
184

LIPOID LLC Lipoid Dotap | 10g

1,2-Dioleoyloxy-3-Trimethylammoniumpropanchloride | 10g

ENCOMPASS
185

eMolecules​ 115288-21-6 | 16:0 Caproylamine PE | Broadpharm805.132 | C43H85N2O9P | 0.000 | CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OCCNC(=O)CCCCCN)OC(=O)CCCCCCCCCCCCCCC | 25mg | 718091965

16:0 Caproylamine PE | Broadpharm | 115288-21-6805.132 | C43H85N2O9P | 0.000 | CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OCCNC(=O)CCCCCN)OC(=O)CCCCCCCCCCCCCCC | 25mg | 718091965

ENCOMPASS_PREFERRED
186

AVANTI POLAR LIPIDS INC 18 1 PI 3 5 P2
SDP

NC2120594 18 1 PI 3 5 P2

ENCOMPASS
187

Avanti Polar Lipids METHYL 10 Z -HEPTADECENOATE1ML
SDP

Methyl 10(Z)-Heptadecenoate 1ml

ENCOMPASS
188

RANDOX LIPOPROTEIN A CONTROL LEVEL
SDP

NC2308065 LIPOPROTEIN A CONTROL LEVEL

ENCOMPASS_PREFERRED
189

Avanti Polar Lipids 18 1-D7 LYSO PC
SDP

18 1-d7 Lyso PC1-oleoyld7-2-hydroxy-sn-glycero-3-phosphocholine1mg

ENCOMPASS
190

Medchemexpress LLC MEDCHEMEXPRESS LLC
SDP

5000734798 DSPC GMP LIKE 500MG

ENCOMPASS_PREFERRED
191

Avanti Polar Lipids 330820 ULTIMATESPLASH ONE
SDP

330820 UltimateSPLASH ONEUltimateSPLASH ONE Internal Standard for Lipidomic Analysis

ENCOMPASS
192

Avanti Polar Lipids 18:1 CY7 PE CHLOROFORM
SDP

1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-N-(Cyanine 7)

ENCOMPASS
193

Medchemexpress LLC D-Lin-MC3-DMA | 1224606-06-7 | MFCD31657426 | 50 mg
SDP

D-Lin-MC3-DMA | Purity: ≥98.0% | Mol Wt: 642.102 | 1224606-06-7 | MFCD31657426 | 50 mg

ENCOMPASS_PREFERRED
194

Medchemexpress LLC MEDCHEMEXPRESS LLC
SDP

5000738300 DSPE-PEG2000-AMINE 100MG

ENCOMPASS_PREFERRED
195

Medchemexpress LLC DSPE-PEG2000-Mal-Cys-YHWYGYTPQNVI | 95.3% | 2000 (Average) | 50 MG
SDP

DSPE-PEG2000-GE11 is a nanocarrier component composed of DSPE and the EGFR-targeting peptide (GE11). It specifically binds to EGFR, mediating receptor-mediated endocytosis of micellar drug carriers for drug delivery.

  • Specifically binds to EGFR.
  • Mediates receptor-mediated endocytosis of micellar drug carriers.
  • Enhances EGFR-dependent cellular uptake of doxorubicin (1.4-fold higher in SMMC-7721 cells).
  • Inhibits HUVEC proliferation, induces G2-M phase arrest, reduces cell migration, and alters HUVEC morphology when modified.
  • Enhances tumor accumulation of DiR-loaded micelles in EGFR-positive hepatocellular carcinoma xenografts.
  • Confers EGFR-targeted accumulation to liposomal formulations in liver cancer xenografts.

ENCOMPASS_PREFERRED